Evaluation of gut modulatory and bronchodilator activities of Amaranthus spinosus Linn.
© Chaudhary et al.; licensee BioMed Central Ltd. 2012
Received: 9 March 2012
Accepted: 25 September 2012
Published: 1 October 2012
The aqueous-methanolic extract of Amaranthus spinosus (A. spinosus Linn.,) whole plant, was studied for its laxative, spasmolytic and bronchodilator activities to validate some of its medicinal uses.
The crude extract of A. spinosus was studied in-vivo for bronchodilator and laxative activities and in-vitro using isolated tissue preparations which were mounted in tissue baths assembly containing physiological salt solutions, maintained at 37°C and aerated with carbogen, to assess the spasmolytic effect and to find out the possible underlying mechanisms.
In the in-vivo experiments in mice, the administration of A. spinosus increased fecal output at doses of 100 and 300 mg/kg showing laxative activity. It also inhibited carbachol-induced bronchospasm in anesthetized rats at 1, 3, 10 and 30 mg/kg indicative of bronchodilator activity. When tested on isolated gut preparations, the plant extract showed a concentration-dependent (0.01-10.0 mg/ml) spasmogenic effect in spontaneously contracting rabbit jejunum and guinea-pig ileum. The spasmogenic effect was partially blocked in tissues pretreated with atropine (0.1 μM). When tested on K+ (80 mM)-induced sustained contractions in isolated rabbit jejunum, the plant extract caused complete relaxation and also produced a shift in the Ca++ concentration-response curves (CRCs) towards right, similar to diltiazem. In rabbit trachea, the plant extract completely inhibited K+ (80 mM) and carbachol (CCh, 1 μM)-induced contractions at 1 mg/ml but pretreatment of tissue with propranolol (1 μM), caused around 10 fold shift in the inhibitory CRCs of the plant extract constructed against CCh-induced contraction. The plant extract (up to 0.3 mg/ml) also increased both force and rate of spontaneous contractions of isolated guinea-pig atria, followed by relaxation at higher concentration (1.0-5.0 mg/ml). The cardio-stimulant effect was abolished in the presence of propranolol, similar to that of isoprenaline. Activity-directed fractionation revealed that the spasmolytic component(s) was separated in the organic fraction, whereas the spasmogenic component was concentrated in the aqueous fraction.
These results indicate that A. spinosus possesses laxative activity partially mediated through cholinergic action. The spasmolytic effect was mediated through calcium channel blocking (CCB), while bronchodilator activity through a combination of β-adrenergic and CCB pathways, which may explain the traditional uses of A. spinosus in gut and airways disorders.
KeywordsAmaranthus spinosus Laxative Spasmolytic Bronchodilator Cholinergic Ca++ antagonist
Amaranthus spinosus Linn. (Family, Amaranthaceae), commonly known as Prickly amaranth and locally in Paksitan as Khaddar-chaulai, is a spinous weed cultivated throughout tropical and subtropical countries for its use as vegetable and also as an animal feed [1, 2]. The plant is highly nutritive due to the presence of fibre, proteins and high concentration of essential amino acids, especially lysine . Besides its culinary value, it is a popular medicinal plant reputed for antipyretic, appetizer, diuretic, febrifuge, galactagogue, haematinic, laxative and stomachic effects and as a treatment for hallucination, leprosy, eczema and piles . It is also useful in bronchitis, leucorrhoea, menorrhagia, boils, burns, nausea, flatulence and colic , healing of wounds and rheumatism , and to arrest the coughing up of blood . All parts of the plant are known to contain medicinally active constituents .
Different studies have evaluated A. spinosus for the presence of antioxidant , antinociceptive , hepato-protective , anti-diabetic, anti-hyperlipidemic, spermatogenic  and antimalarial  activities.
Phytochemical studies revealed that the plant contains alkaloids, flavonoids, glycosides, phenolic acids, steroids, amino acids, terpenoids, lipids, saponins, betalains, β-sitosterol, stigmasterol, linoleic acid, rutin, catechuic tannins and carotenoids . The betalains in stem bark of A. spinosus were identified as amaranthine, isoamaranthine, hydroxycinnamates, quercetin and kaempferol glycosides [11–15]. It also contains amaranthoside, a lignan glycoside, amaricin, a coumaroyl adenosine along with stigmasterol glycoside, betaine such as glycinebetaine and trigonelline [16, 17].
Despite the wide medicinal uses of A. spinosus, no data are available with respect to its effectiveness in gut motility and airways disorders. The present study on the crude extract of A. spinosus and its fractions was undertaken to rationalize these traditional uses and to explore mechanistic basis for these medicinal uses.
Fresh whole plant of A. spinosus Linn. was collected from the fields of Bahauddin Zakariya University Multan, Pakistan, and was identified by an expert taxonomist of the Institute of Pure and Applied Biology, Bahauddin Zakariya University, Multan. A specimen is deposited in Herbarium of the Institute (voucher # Fl.P.231-2).
Preparation of crude extract and fractions
Following shade drying, the plant material was manually made free from soil and other adulterants and was ground to coarse powder by an electrically driven mill. Approximately 400 g powdered plant material was soaked in 70% aqueous-methanol by cold maceration at room temperature for 7 days with occasional shaking . It was filtered through a double layered muslin cloth and subsequently through a filter paper. The residue was re-soaked in the fresh solvent and the process was repeated thrice to get maximum yield of crude extract from the plant material. The combined filtrate was concentrated in rotary evaporator at 40°C under reduced pressure (−760 mmHg) to a thick, semi-solid mass, the crude extract of A. spinosus whole plant (As.Cr), weighing 44.52 gm with approximated yield of 11.13%. A. spinosus was transfer to a glass bottle and stored at −20°C until used. The stock solutions of A. spinosus were prepared in distilled water and the dilutions were made fresh in normal saline on the day of experiment.
For the purpose of fractionation, 10 gm of the crude extract was dissolved in water and shaken with ethyl acetate in a separating funnel. Two layers of the immiscible solvents were allowed to separate. The ethyl acetate layer was collected whereas the aqueous layer was re-extracted with fresh ethyl acetate for a total of three times. The ethyl acetate layers, so collected, were combined and then dried on a rotary evaporator to yield the ethyl acetate fraction (As.EtAc) weighing 0.3 gm. The aqueous layer left after extraction with ethyl acetate was evaporated separately to obtain the aqueous fraction (As.Aq) weighing 9.7 gm. Approximate yields of As.EtAc and As.Aq were 3% and 97% of the crude extract, respectively. The As.EtAc was solubilized by the following method; a solution of Tween-80 (100 mg/ml in ethyl acetate) was prepared, and 0.1 ml of this solution was added to the solution of As.EtAc (300 mg/ml) in ethyl acetate and shaken. The solvent was then evaporated on a hot plate and the resultant extract was suspended in water (1 ml) by vigorous shaking. The concentration of this stock is considered as 300 mg/ml .
Drugs and reagents
All the chemicals used in the experiments were of highest purity and research grade and were obtained from the sources specified: acetylcholine chloride, atropine sulfate, aminophylline, carbachol, diltiazem, histamine, isoprenaline, pyrillamine, potassium chloride and phenylephrine from Sigma Chemicals Co. St Louis, MO, USA, calcium chloride, glucose, magnesium chloride, magnesium sulphate, potassium dihydrogen phosphate, sodium bicarbonate, sodium dihydrogen phosphate and methanol from Merck, Darmstadt, Germany, and ammonium hydroxide, sodium chloride and sodium hydroxide from BDH Laboratory Supplies, Poole, England.
Rabbits (1.0-1.5 kg), guinea-pigs (500-600 g) and BALB/c mice (20-30 g) of local breed and either sex, used for the experimental work, were housed under controlled environmental condition (23-25°C) at the Animal House of Aga Khan University, Karachi. Animals were given standard diet and tap water. Animals were kept at fasting 24 h prior to the experiments but had free access to water. Rabbits and guinea-pigs used for in-vitro study were sacrificed by blow on the back of head and cervical dislocation, respectively. Mice were used for the in-vivo laxative activity. Experiments performed complied with the rulings of Institute of Laboratory Animal Resources, Commission on Life Sciences  and approved by the Ethical Committee of the Aga Khan University.
Mice were used as experimental animals to study the laxative activity of A. spinosus in comparison with carbachol, by following a previously described method . The food supply was restricted to the mice 24 h prior to the experiment but there was a free access to water. The animals, kept individually in cages lined with clean blotting sheets, were divided into five groups containing five mice each to receive different treatments, orally. Group 1, taken as the negative control, was administered with normal saline (10 ml/kg), Group 2, the positive control group, was administered with carbachol (1 mg/kg), while the Groups 3, 4 and 5, the test groups, received 100, 300 & 500 mg/kg of the crude extract of A. spinosus, respectively. All five groups were monitored for 18 h; total number of feces was counted for each mouse and the average number of feces was calculated for each group.
Effect on CCh-induced bronchospasm
Rats were anaesthetized with sodium thiopental (Pentothal, 80–100 mg/kg, i.p.) and underwent endotracheal intubation followed by ventilation with a volume ventilator (Miniature ideal pump, Bioscience, UK) adjusted at a rate of 70–80 strokes/min to deliver 7–10 ml/kg of room air . A polyethylene catheter was inserted into the jugular vein for drug administration. The changes in airways resistance (mmHg) were measured by a pressure transducer (MLT-1199) connected to PowerLab 4/25 with running chart software via Quad bridge amplifier (AD Instruments, Bella Vista, NSW, Australia). Bronchoconstriction was induced with CCh (100 μg/kg), which was reversed within 7–10 min. The test drug was given to the animals 5–8 min prior to administration of CCh. The responses were expressed as the percent reduction of the CCh-induced bronchospasm .
Plant extract was screened for its spasmogenic and spasmolytic activities on isolated rabbit jejunum. Segments of approximately 2 cm length were suspended in a 10 ml tissue bath containing Tyrode’s solution having the following composition in mM: KCl 2.68, NaCl 136.9, MgCl2 1.05, NaHCO3 11.90, NaH2PO4 0.42, CaCl2 1.8 and glucose 5.55, aerated with carbogen (95% O2 and 5% CO2) and maintained at 37°C. Each tissue was given 1 g pretension, allowed to equilibrate for at least 30 min and stabilized with the repeated exposure to 0.3 μM acetylcholine, ACh (3–5 times) and subsequent washing with the Tyrode’s solution until the sub-maximal responses of equal amplitude were obtained. The dose–response curves of acetylcholine were constructed before the addition of test materials. Maximum response of the tissue to acetylcholine was considered to have been achieved when the next higher concentrations of the agonist failed to produce a further increase in response . The contractile effect of the test materials was assessed as percent of the maximum effect produced by the control drug, ACh. Intestinal responses were obtained isotonically using BioScience transducers and Powerlab data acquisition system (AD Instruments, Sydney, Australia) attached to a computer installed with Labchart software (version 6).
Determination of Ca++ antagonist effect
To assess whether the relaxant effect of the crud extract was through calcium channel blocking activity, K+ (80 mM) was used to depolarize the preparations as described by Farre et al. . K+ (80 mM) was added to induce the sustained contraction. The crud extract was then added to the tissue bath in a cumulative fashion to obtain concentration-dependent inhibitory responses . The relaxation of intestinal preparations, pre-contracted with K+ (80 mM) was expressed as percent of the control response mediated by K+. To confirm the calcium antagonist activity of the crud extract, the tissue was allowed to stabilize in normal Tyrode’s solution, which was then replaced with Ca++-free Tyrode’s solution containing EDTA (0.1 mM) for 30 min in order to remove Ca++ from the tissues. This solution was further replaced with K+-rich and Ca++-free Tyrode’s solution, having the following composition in mM: KCl 50, NaCl 91.04, MgCl2 1.05, NaHCO3 11.90, NaH2PO4 0.42, glucose 5.55 and EDTA 0.1. Following an incubation period of 30 min, control concentration–response curves of Ca++ were constructed. When the control CRCs of Ca++ were found super-imposable (usually after two cycles), the tissue was pretreated with the crude extract for 50 min to test the possible calcium channel blocking effect. The CRCs of Ca++ were reconstructed in the presence of different concentrations of the test material, diltiazem was used as a positive control.
The ileum was dissected out and segments of approximately 2 cm length were suspended individually in a 10 ml tissue bath, filled with Tyrode’s solution and aerated with carbogen at 37°C . A preload of 1 g was applied to each tissue and kept constant throughout the experiment. Following an equilibration period of 30 min, isotonic contractions to ACh (0.3 μM) were repeated to stabilize the preparation. The stimulant effect of the extract was determined on the resting baseline of the tissue and was assessed as percent of the maximum effect produced by the reference drug, ACh.
Trachea was dissected out, cleaned free from the surrounding fatty tissues and cut into rings having 2–3 mm width (containing 2 cartilages). Each ring was then cut longitudinally on the site opposite to the smooth muscle layer in such a way that smooth muscles were in between the C-shaped cartilaginous part. The isolated preparations were then mounted in a 15 ml tissue bath containing Kreb’s solution having the following composition in mM: NaCl 118.2, NaHCO3 25.0, CaCl2 2.5, KCl 4.7, KH2PO4 1.3, MgSO4 1.2 and glucose 11.7, aerated with carbogen at 37°C. The mounted tissue preparations were given 1 g pre-tension and equilibrated for 1 h before the addition of any chemical substance. To induce sustained contractions, carbachol (1 μM) and high K+ (80 mM) were used and the bronchodilator activity was studied by adding plant extract in a cumulative manner. Isometric responses were obtained with the help of BioScience transducers and recorded through PowerLab data acquisition system .
Right atrium from the healthy guinea-pig was dissected out, cleaned off fatty tissues and mounted in a 15 ml tissue bath containing Kreb’s solution aerated with carbogen at 32°C . The tissue exhibited spontaneous beating under the resting tension of 1 g due to the presence of pacemaker cells. An equilibrium period of 30 min was provided before the application of any chemical substance. This preparation allowed us to study the effect of the test substance on both rate and force of spontaneous atrial contractions. The data obtained represent the force of atrial contractions, while rate of atrial contractions was obtained by increasing speed of the chart. The control responses of isoprenaline (1 μM) were obtained at least in duplicate. Isometric responses were obtained with the help of BioScience transducers and recorded through PowerLab data acquisition system.
The data are expressed as mean ± standard error of the mean (S.E.M., n = number of experiments) or the median effective concentrations (EC50 values) given with 95% confidence intervals (CI). The statistical parameter applied is the Student’s t-test and One-way analysis of variance (ANOVA) followed by Dunnett’s test. P < 0.05 is considered as significant.
In vivo experiments
In vitro experiments
Effect on rabbit jejunum
Effect on guinea-pig ileum
Effect on rabbit trachea
Effect on guinea-pig atria
Effect of fractions on rabbit jejunum
The aqueous fraction (As.Aq) produced a concentration-dependent spasmogenic effect at 0.01-10.0 mg/ml (Figure 9b) with maximum spasmogenic effect of 96.28 ± 8.10% ; (n = 5) close to ACh-induced maximum response (P > 0.05), followed by relaxation when tissue was left unwashed for some time and showed weak inhibitory effect on K+ (80 mM)-induced contraction.
In view of its medicinal use in gastrointestinal and airways disorders, the crude extract of A. spinosus was subjected to pharmacological investigation in order to validate the medicinal uses and explore possible underlying mechanisms.
To observe its laxative effect, the plant extract was administered orally to healthy mice, which produced a dose-dependent laxation at 100 and 300 mg/kg, similar to carbachol (1 mg/kg). A further increment in dose (500 mg/kg) decreased the fecal output possibly due to the presence of spasmolytic component along with spasmogenic constituents. In addition, there are multiple reports showing the safety of plant administration in experimental animals at around 4 times higher doses than the highest dose tested in this study [32, 33].
To explore the possible mechanism possibly underlying its laxative effect, the crude extract was tested on spontaneously contracting rabbit jejunum, where it showed a concentration-dependent spasmogenic effect followed by relaxation when the tissue was left unwashed for some time. The spontaneous movement of intestine is regulated by periodic depolarization and re-polarization and the peak of depolarization is represented by action potential generated due to the rapid influx of Ca++ via voltage dependant L-type Ca++ channels (VDLCs) . Maximum spasmogenic effect of the crude extract was found similar to ACh-induced maximum contractile response suggesting the high efficacy of its spasmogenic effect. To see if the gut stimulant effect was mediated through cholinergic activity, the stimulant effect was challenged by atropine (0.1 μM), a known muscarinic receptor antagonist . In the presence of atropine, the contractile effect of the extract was partly blocked, indicating the presence of cholinergic constituent(s) and some additional mechanism(s) responsible for the observed stimulant effect. The use of the specific antagonists also ruled out the possible presence of any histaminergic, serotonergic or nicotinic activity in the crude extract of A. spinosus mediating its spasmogenic effect (data not shown).
The gut stimulant effect of the crude extract was further studied on guinea-pig ileum, a quiescent preparation considered useful for this purpose . The plant extract exhibited dose dependent contractions in guinea-pig ileum partly suppressed by atropine, a similar pattern of activity was observed in jejunum thus confirming the involvement of more than one pathway in the spasmodic effect of the plant extract. Results of this study indicate the presence of spasmogenic constituents in the plant that may account for its medicinal use in constipation and also invite further experimental work to explore the exact nature of additional spasmogenic component.
The spasmogenic effect in gut preparations was followed by spontaneous relaxation when the tissues were left unwashed for some time, indicating the presence of spasmolytic component in combination with spasmogenic activity. In our previous studies we have noticed the presence of Ca++ channel blocking activity in plants as mechanism usually underlying their spasmolytic effect [30, 36, 37]. To see, whether the relaxant effect of A. spinosus is mediated through the same mechanism, the tissue was pretreated with high K+ (80 mM), which produced a sustained contraction. The contractile response induced by high concentration of K+ (80 mM) is due to release and influx of extracellular Ca++ through L-type voltage-sensitive channels . The plant extract completely relaxed the K+ (80 mM)-induced contraction in isolated rabbit jejunum indicating the Ca++ channel blocking activity. The presence of CCB activity in A. spinosus was further strengthened when the plant extract shifted the Ca++ CRCs towards right, similar to diltiazem, a standard Ca++ channel blocker . The presence of spasmolytic activity in the plant mediated through CCB mechanism may be responsible for its medicinal use in abdominal colic and perhaps also meant by nature to offset the excessive gut stimulant action that is usually observed with chemical drugs.
The plant material has traditionally been used for the management of respiratory diseases like asthma and bronchitis. To see the possible bronchodilator activity, the crude extract was tested on CCh-induced bronchospasm in anesthetized rats, where it caused a dose-dependent inhibition of CCh-induced bronchoconstriction, similar to aminophylline, a known bronchodilator agent . To further explore the possible mechanism in its bronchodilator activity, the plant extract was tested on rabbit tracheal preparations precontracted with high K+ or CCh. The crude extract completely relaxed high K+ and CCh-induced contractions at similar concentration, whereas, diltiazem was more potent against K+ induced contraction, a typical characteristic of a pure CCB . The CCB component in A. spinosus was confirmed when it shifted the Ca++ CRCs constructed in rabbit trachea towards right, similar to diltiazem. The Ca++ channel blockers have been found to be useful in bronchospastic disorders [40, 41]. To see, if the bronchodilator effect of the crude extract was mediated through β2-agonist activity, inhibitory effect of the plant extract on CCh-induced spasms was tested in the presence of propranolol (1 μM), a non-specific β–adrenergic receptor antagonist . In the presence of propranolol, the relaxant effect of A. spinosus extract on CCh-induced contraction was observed at significantly higher concentration, indicating the presence of β–adrenergic activity. The β2–adrenergic agonists are widely used in clinical practice as bronchodilator agents .
Interestingly, the crude extract of A. spinosus increased force of contraction followed by relaxation at the higher concentration. The cardio-tonic effect was diminished in tissues pretreated with propranolol and the relaxant effect became more prominent. The cardio-stimulant effect of adrenergic drugs is mediated through β1-adrenergic receptors, whereas is bronchodilator effect through β2 adrenergic receptors . Presence of a combination of cardio-stimulant and bronchodilator activity, suppressed by propranolol, confirmed the presence of non-specific β-adrenergic agonist activity similar to that of isoprenaline. Isoprenaline, though very effective bronchodilator, but has limited clinical use due to associated cardiac stimulation as side-effect . Interestingly, when tested on heart, there was mild ionotropic effect but no significant increase was observed on hear rate at low dose, while inhibitory effect was observed at higher doses. This is perhaps because of co-existence of cardiac stimulant (β1) and cardiac depressant activity due to CCB constituents, which has opposing effect in the heart, while additive and/or synergistic interactions with bronchodilator activity, a desired effect in air ways disorders. The β-adrenergic activity of A. spinosus was not seen in jejunal preparations that may be due to the cardiac and bronchial tissue selectivity of β-adrenergic effect.
Activity-directed fractionation revealed that the spasmolytic effect of the crude extract of A. spinosus was mainly concentrated in the ethyl acetate fraction which caused inhibition of spontaneous as well as K+-induced contraction, whereas the spasmogenic effect was concentrated in the aqueous fraction along with a weak spasmolytic activity. This pattern of separating biological activities among the fractions is in accordance with our previous findings, that the spasmogenic activity of crude plant extracts is usually concentrated in the aqueous fractions while the spasmolytic component is concentrated in organic fractions [43, 44]. We also speculate that the spasmogenic component of the plant may not get absorbed systemically due to its polar nature as reflected by its water solubility and would not be able to interfere with its bronchodilator activity.
These data, suggesting the presence of laxative effect in the plant mediated partly through cholinergic action, spasmolytic effect through CCB activity and bronchodilator activity through a combination of CCB and β-agonistic activities, explain the medicinal use of A. spinosus in constipation, abdominal colic and airways disorders. Such coexistence of β-agonist activity with CCB constituents offers synergistic and side-effect neutralizing potential, a typical characteristic of natural products .
- A. spinosus :
The crude extract of A. spinosus
The ethyl acetate fraction of the crude extract of A. spinosus
The aqueous fractions of the crude extract of A. spinosus
Ca++ channel blockade
Median effective concentration
Number of experiments
Voltage dependent L-type Ca++ channels.
This study was supported partly by Pakistan Science Foundation and the University Research Council of the Aga Khan University, Karachi, Pakistan.
- Baquar SR: Medicinal and Poisonous Plants of Pakistan. 1989, Karachi, Printa
- Kirtikar KR, Basu BD: Indian Medicinal Plants. 2001, Oriental Enterprises, Uttranchal
- Teutonico RA, Knorr D: Amaranth: composition, properties and applications of a rediscovered food crop. Food Technology. 1985, 39: 49-60.
- Longman O: Indian Medicinal Plants. 2003, Orient Longman Private Limited, Chennai
- Wiart C: Medicinal Plants of Southeast Asia. 2002, Pearson Malaysia Sdn. Bhd, Petaling Jaya
- Khare CP: Indian Herbal Remedies. Rational Western Therapy Ayurvedic. 2004, Springer, New DelhiView Article
- Hussain Z, Amresh G, Singh S, Rao CV: Hepatoprotective and antioxidant activity of Amaranthus spinosus against CCl4 induced toxicity. J Ethnopharmacol. 2009, 125: 364-366. 10.1016/j.jep.2009.05.010.View Article
- Hussain Z, Amresh G, Rao CV, Singh S: Antinociceptive activity of Amaranthus spinosus in experimental animals. J Ethnopharmacol. 2009, 122: 492-496. 10.1016/j.jep.2009.01.031.View Article
- Hussain Z, Amresh G, Rao CV, Singh S: Hepatoprotective activity of Amaranthus spinosus in experimental animals. Food Chem Toxicol. 2008, 46: 3417-3421. 10.1016/j.fct.2008.08.013.View Article
- Sangameswaran B, Jayakar B: Anti-diabetic, anti-hyperlipidemic and spermatogenic effects of Amaranthus spinosus Linn. on streptozotocin-induced diabetic rats. J Nat Med. 2008, 62: 79-82.View ArticlePubMed
- Hilou A, Nacoulma OG, Guiguemde TR: In vivo antimalarial activities of extracts from Amaranthus spinosus L. and Boerhaavia erecta L. in mice. J Ethnopharmacol. 2006, 103: 236-240. 10.1016/j.jep.2005.08.006.View ArticlePubMed
- Srinivasan K, Kaul CL, Ramarao P: Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice. Indian J Pharmacol. 2005, 37: 327-328. 10.4103/0253-7613.16859.View Article
- Ibewuike JC, Ogundaini AO, Bohlin L, Ogungbamila FO: Antiinflammatory activity of selected Nigerian medicinal plants. Nig J Nat Prod And Med. 1997, 1: 10-14.
- Rastogi RP, Mehrotra BN: Compendium of Indian Medicinal Plants. 1999, CDRI and NISCAIR, Lucknow
- Stintzing FC, Kammerer D, Schieber A, Hilou A, Nacoulma O, Carle R: Betacyanins and phenolic compounds from Amaranthus spinosus and Boerhaavia erecta. Z Naturforsch C. 2004, 59: 1-8.View ArticlePubMed
- Blunden G, Yang M, Janicsak MI, Carabot-Cuervo A: Betaine distribution in the Amaranthaceae. Biochem Syst Ecol. 1999, 27: 87-92. 10.1016/S0305-1978(98)00072-6.View Article
- Azhar-ul-Haq M, Afza N, Khan SB, Muhammad P: Coumaroyl adenosine and lignan glycoside from Amaranthus spinosus Linn. Pol J Chem. 2006, 80: 259-263.
- Williamson EM, Okpako DT, Evans FJ: Selection, Preparation and Pharmacological Evaluation of Plant Material. 1998, John Wiley & Sons, Chichester
- Gilani AH, Aziz N, Khurram IM, Rao ZA, Ali NK: The presence of cholinomimetic and calcium channel antagonist constituents in Piper betle Linn. Phytother Res. 2000, 14: 436-442. 10.1002/1099-1573(200009)14:6<436::AID-PTR620>3.0.CO;2-C.View ArticlePubMed
- National Research Council: Guide for the Care and Use of Laboratory Animals. 1996, National Academy Press, Washington DC, 1-5.
- Haruna AK: Cathartic activity of soborodo: the aqueous extract of calyx of Hibiscus sabdariffa L. Phytother Res. 1997, 11: 307-308. 10.1002/(SICI)1099-1573(199706)11:4<307::AID-PTR42>3.0.CO;2-R.View Article
- Khan A, Gilani AH: Antidiarrheal and bronchodilatory activities of olive extract. Lat Am J Pharm. 2011, 30: 5-9.
- Gilani AH, Shaha AJ, Zubaira A, Khalida S, Kiania J, Ahmed A, Rasheed M, Ahmad VU: Chemical composition and mechanisms underlying the spasmolytic and bronchodilatory properties of the essential oil of Nepeta cataria L. J Ethnopharmacol. 2009, 121: 405-411. 10.1016/j.jep.2008.11.004.View ArticlePubMed
- Gilani AH, Mandukhail SU, Iqbal J, Yasinzai M, Aziz N, Khan A, Rehman NU: Antispasmodic and vasodilator activities of Morinda citrifolia root extract are mediated through blockade of voltage dependent calcium channels. BMC Complement Altern Med. 2010, 10: 2-10.1186/1472-6882-10-2.PubMed CentralView ArticlePubMed
- Jabeen Q, Bashir S, Lyoussi B, Gilani AH: Coriander fruit exhibits gut modulatory, blood pressure lowering and diuretic activities. J Ethnopharmacol. 2009, 122: 123-130. 10.1016/j.jep.2008.12.016.View ArticlePubMed
- Gilani SAH, Cobbin LB: Cardioselectivity of himbacine: a muscarine receptor antagonist. Naunyn Schmiedeberg’s Arch Pharmacol. 1986, 332: 16-20. 10.1007/BF00633191.View Article
- Farre AJ, Colombo M, Fort M, Gutierrez B: Differential effects of various Ca++ antagonists. Gen Pharmacol. 1991, 22: 177-181. 10.1016/0306-3623(91)90331-Y.View ArticlePubMed
- Van-Rossum JM: Cumulative concentration-response curves. II. Techniques for the making of concentration-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963, 143: 299-330.PubMed
- Rehman NU, Mehmood HM, Al-Rehaily AJ, Mothana RAA, Gilani AH: Species and tissue-specificity of prokinetic, laxative and spasmodic effects of Fumaria parviflora. BMC Complement Altern Med. 2012, 12: 16-10.1186/1472-6882-12-16.View Article
- Gilani AH, Shah AJ, Ghayur MN, Majeed K: Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci. 2005, 76: 3089-3105. 10.1016/j.lfs.2004.12.021.View ArticlePubMed
- Gilani AH, Shaheen F, Christopoulos A, Mitchelson F: Interaction of ebeinone, an alkaloid from Fritillaria imperialis, at two muscarinic acetylcholine receptor subtypes. Life Sci. 1997, 60: 535-544. 10.1016/S0024-3205(96)00691-1.View ArticlePubMed
- Kumar ABS, Lakshman K, Nandeesh R, Kumar APA, Manoj B, Kumar V, Shekar DS: In vitro alpha-amylase inhibition and in vivo antioxidant potential of Amaranthus spinosus in alloxan-induced oxidative stress in diabetic rats. Saudi J Bio Sci. 2011, 18: 1-5. 10.1016/j.sjbs.2010.08.002.View Article
- Kumar MKS, Rajesh V, Kumar SS, Perumal P: Evaluation of analgesic activity of Amaranthus spinosus Linn. Leaves in mice. J Pharm Res. 2010, 3: 3088-3089.
- Brading AF: How do drugs initiate contractions in smooth muscles. Trends Pharmacol Sci. 1981, 2: 261-265.View Article
- Brown JH, Taylor P: Cholinergic agonists. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Edited by: Brunton LL, Lazo JS, Parker KL. 2006, McGraw-Hill, New York, 845-868. 11
- Gilani AH, Ghayur MN, Khalid A, Haq ZU, Choudhary MI, Rahman AU: Presence of antispasmodic, antidiarrheal, antisecretory, calcium antagonist and acetylcholinesterase inhibitory steroidal alkaloids in Sarcocca saligna. Planta Med. 2005, 71: 1-6.View Article
- Gilani AH, Bashir S, Janbaz KH, Shah AJ: Presence of cholinergic and calcium channel blocking activities explains the traditional use of Hibiscus rosasinensis in constipation and diarrhea. J Ethnopharmacol. 2005, 102: 289-294. 10.1016/j.jep.2005.07.023.View ArticlePubMed
- Hoffman BB: Therapy of Hypertension. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Edited by: Brunton LL, Lazo JS, Parker KL. 2006, McGraw-Hill, New York, 845-868. 11
- Undem BJ: Pharmacotherapy of Asthma. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Edited by: Brunton LL, Lazo JS, Parker KL. 2006, McGraw-Hill, New York, 717-736. 11
- Ahmed T: Calcium antagonists: potential for asthma therapy. Choices Respir Manage. 1992, 22: 41-43.
- Mathewson HS: Anti-asthmatic properties of calcium antagonists. Respir care. 1985, 30: 770-781.
- Westfall TC, Westfall DP: Adrenergic agonists and antagonists. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Edited by: Brunton LL, Parker KL. 2006, McGraw Hill, New York, 148-187. 11
- Bashir S, Janbaz KH, Jabeen Q, Gilani AH: Spasmogenic and spasmolytic activities of Calendula officinalis flowers. Phytother Res. 2006, 20: 906-910. 10.1002/ptr.1980.View ArticlePubMed
- Mehmood MH, Aziz N, Ghayur MN, Gilani AH: Pharmacological basis for the medicinal use of Psyllium husk (Ispaghula) in constipation and diarrhea. Dig Dis Sci. 2010, 56: 1460-1471.View ArticlePubMed
- Gilani AH, Rahman A: Trends in ethnopharmacology. J Ethnopharmacol. 2005, 100: 43-49. 10.1016/j.jep.2005.06.001.View ArticlePubMed
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/166/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.